November 30, 2022 at 10:16PM FDA Approves First Fecal Microbiota Product

FDA approves the first fecal microbiota product, Rebyota. Rebyota is approved for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older. It is for used after an individual has completed antibiotic treatment for recurrent CDI.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bMCU2OF